Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
NEW YORK (Reuters Health) - Breast cancer is often considered more deadly among younger women, but a new study shows older women are actually more likely to die of the disease.
WASHINGTON (Reuters) - Reviewers from the U.S. Food and Drug Administration said on Monday that they were not sure whether Amgen Inc's Xgeva bone drug should be approved for a wider use of delaying the spread of cancer to the bone.
Learn how the combination of everolimus and the hormonal therapy exemestane may offer a new treatment option for postmenopausal women with locally advanced or metastatic estrogen-receptor positive, HER2-negative breast cancer.
NEW YORK (Reuters Health) - One in four women who have breast-conserving surgery for cancer needs a second operation to remove more breast tissue, suggests a new study that also found the rate of re-operation varied widely by surgeon.
Learn how the experiemental medicine pertuzumab improves progression-free survival and may offer a new treatment option for women with metastatic HER2 positive breast cancer.
Learn how the Oncotype DX DCIS Score predicts recurrence and adds treatment options in early-stage breast cancer.
If you have been diagnosed with early-stage breast cancer and are exploring your treatment options, learn why axillary surgery may not be necessary.
NEW YORK (Reuters Health) - About one third of breast cancer survivors experience fatigue that can affect their quality of life, but a small new study finds that doing yoga might help restore some lost vitality.
NEW YORK (Reuters Health) - In a new survey of breast cancer survivors, few people said that having a follow-up appointment with a doctor or nurse over the phone or online instead of in person would ease their stress and worry.
NEW YORK (Reuters Health) - Women treated for breast cancer with radiation with or without chemotherapy had more thinking and memory problems a few years after their treatment ended than women who'd never had cancer, in a new study.